Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8937 - 8944 of 12017 results
Jury Sides with DOJ in First Phase of FCA Statistical Sampling Trial
October 21, 2015| Blog| Viewpoint
ML Strategies: Medicare Cuts in the Crosshairs of a Budget Agreement?
October 21, 2015| Blog| Viewpoint
Mintz's Meghan Burke Awarded Freda Johnson Award for Trailblazing Women in Public Finance
October 21, 2015| Blog| Viewpoint
FTC Sets Berks County’s Broken Orthopedic Market
October 20, 2015| Alert| Viewpoint
What The Future Holds For Global Energy: Paul Dickerson To Speak At 40th Annual ICA Conference
October 20, 2015| Blog| Viewpoint
SCOTUS to Hear a Duo on Willful Patent Infringement
October 20, 2015| Blog| Viewpoint
Does Invalidation of 340B Orphan Drug Rule Doom HRSA’s Guidance?
October 20, 2015| Blog| Viewpoint
Irish High Court Quashes Irish Data Protection Commission Original Schrems' Decision
October 20, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|